Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.
Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations.
The developers of sustained acoustic medicine technology and the sam® wearable ultrasound device continue mission of ...
GlobalData on MSN
FDA clears Varian’s TrueBeam systems for low-dose radiation therapy in osteoarthritis
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...
Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...
GlobalData on MSN
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.
RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...
Tom Nolan reviews this week’s research GLP-1 receptor agonists, now widely used for diabetes, cardiovascular disease, and weight loss, seem to be as effective for these indications regardless of age, ...
Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam, and Edge, have received FDA 510(k) clearance for the use of low-dose ...
Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research highlights immune cells as treatment targets.
Torbjörn Ogéus discusses the next frontier in regenerative medicine for osteoarthritis, from innovation to clinical validation and standard of care ...
The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results